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A central challenge for the future perspective of cardiac regenerative
medicine is the generation of large numbers of patient-specific cardiac
myocytes. Ccbe1 encodes a secreted molecule that was firstly identified
using an Affymetrix GeneChip differential screen for chick heart precur-
sor cells expressed genes (Bento et al., 2011). In mouse and chick,
Ccbe1 is expressed in major cardiac progenitor lineages that contribute
to distinct heart structures during heart organogenesis (Facucho-Olive-
ira et al., 2011). Moreover, analysis of gain and loss of function per-
formed in both mouse and chick embryos showed abnormal cardiac
morphogenesis and aberrant chamber formation further elucidating
the role of Ccbe1 for cardiac development. Similarly, in mouse and
human ES cells, increased levels of Ccbe1 expression were detected
after cardiac lineage commitment demonstrating well-coordinated
expression of various early and late cardiac specific markers and Ccbe1.
Knock-Down in mouse and human ES cells demonstrated the require-
ment of Ccbe1 for proper cardiogenesis. Modulation of mCcbe1 activity
in differentiating mES cells using media supplemented with mCcbe1
recombinant protein has demonstrated a remarkable inductive poten-
tial of mCcbe1 to enhance cardiogenesis. Taken together, this data
strongly suggest that Ccbe1 has the ability to direct the expression of
cardiac inducers and to control cardiac progenitor expansion in vitro
and in vivo, allowing the generation of non-genetically manipulated
cardiac cells from a renewable cell source for regenerative cardiovascu-
lar medicine.
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Objectives: Osteochondral defect is a common condtion in clinic. Satis-
factory outcomes are rarely achieved by traditional methods. Tissue
engineering might be a promising strategy for this hinder. The aim of
this study is to mimick the stratified structure of osteochondral tissue,
by developing a bilayered scaffold for osteochondral regeneration. The
developed bilayered scaffold is composed of a porous silk fibroin scaf-
fold as the cartilage-like layer and a porous silk fibroin/nano-calcium
phosphate (CaP) scaffold as the bone-like layer.
Methods: The silk and silk/nano-CaP bilayered scaffolds were prepared
by a combination of salt-leaching and freeze-drying approaches, as pre-
viously reported [1,2]. Briefly, the concentrated silk fibroion aqueous
solution (16%) was mixed with calcium chloride and ammonium phos-
phate dibasic solution to generate the silk/nano-CaP suspension. The
bottom layer was prepared by adding the sodium chloride particles
(500–1000 lm) into the suspension. A 16% silk fibroin solution was
then added onto the top of the silk/nano-CaP layer. Sodium chloride
particles of the same size were added into the silk solution to produce
the top layer. After 48 h, sodium chloride was leached out from the lay-
ered scaffold and the final bilayered scaffolds were lyophilized. The
generated scaffolds were characterized by SEM, micro-CT, and EDX.
Results and Discussion: SEM images showed that a macro/micro por-
ous structure was observed in both layers. These two layers integrate
well, without the formation of a clear interface. Micro-CT analysis
allowed observing that the layered scaffolds were of porous structure,
with homogeneous porosity distribution in each layer. The CaP was
homogeneously distributed in the bottom layer, while there was no
CaP detected in the top layer. By EDX analysis, the amount of CaP from
the bottom to the top layer was mapped, which presented a gradient
decrease in the interface region, indicating a good integration between
both layers.
Conclusions: Silk fibroin and silk fibroin/nano-CaP bilayered scaffolds
were successfully generated. The porous structure was maintained in
each layer. The CaP was homogeneously distributed only in the bottom
layer, and presented a gradient decrease at the interface. The most
important features of this bilayered construct is the good integration
between the two layers at the interface region. This is important since
when implanted this region can be particularly sensitive to mechanical
stresses. Therefore, this bilayered scaffold may be useful for an osteo-
chondral regeneration approach.
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